Cell-based hepatitis C virus infection fluorescence resonance energy transfer (FRET) assay for antiviral compound...

Area of Science:

• Virology
• Hepatology
• Drug Discovery

Background:

• Hepatitis C virus (HCV) infection is a major global health issue, causing chronic liver disease.
• Limited therapeutic and preventative options necessitate the development of novel HCV antivirals.
• High-throughput screening assays are vital for identifying potential antiviral compounds.

Purpose of the Study:

• To describe methods for assessing the in vitro efficacy of HCV antivirals.
• To introduce a cell-based high-throughput fluorescence resonance energy transfer (FRET) assay for HCV infection screening.
• To enable the identification of inhibitors targeting any stage of the HCV life cycle.

Main Methods:

• Utilizing a cell-based high-throughput FRET assay to screen for HCV infection inhibitors.
• Implementing basic protocols for compound screening and efficacy analysis.
• Employing support protocols for infectious HCV propagation and infectivity measurement.

Main Results:

• The described FRET assay allows for efficient screening of numerous compounds.
• The methodology facilitates the identification of inhibitors effective against HCV infection.
• The assay can detect inhibitors targeting various steps in the viral life cycle.

Conclusions:

• The cell-based high-throughput FRET assay is a valuable tool for discovering novel HCV antivirals.
• This screening approach aids in addressing the global healthcare concern of HCV infection.
• The described methods support the advancement of HCV therapeutic strategies.